D470-0271 Screening compound: N~1~-(5-chloro-2-methoxyphenyl)-2-methoxy-5-(1,1,3-trioxotetrahydro-2H-1lambda~6~-isothiazol-2-yl)-1-benzenesulfonamide

D470-0271 Screening compound: N~1~-(5-chloro-2-methoxyphenyl)-2-methoxy-5-(1,1,3-trioxotetrahydro-2H-1lambda~6~-isothiazol-2-yl)-1-benzenesulfonamide
D470-0271 Screening compound: N~1~-(5-chloro-2-methoxyphenyl)-2-methoxy-5-(1,1,3-trioxotetrahydro-2H-1lambda~6~-isothiazol-2-yl)-1-benzenesulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D470-0271
N~1~-(5-chloro-2-methoxyphenyl)-2-methoxy-5-(1,1,3-trioxotetrahydro-2H-1lambda~6~-isothiazol-2-yl)-1-benzenesulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D470-0271

Molecular Formula

C17H17ClN2O7S2 (C17 H17 ClN2 O7 S2)

Compound Name

N~1~-(5-chloro-2-methoxyphenyl)-2-methoxy-5-(1,1,3-trioxotetrahydro-2H-1lambda~6~-isothiazol-2-yl)-1-benzenesulfonamide

IUPAC name

N-(5-chloro-2-methoxyphenyl)-2-methoxy-5-(113-trioxo-1lambda62-thiazolidin-2-yl)benzene-1-sulfonamide

SMILES

COc(ccc(Cl)c1)c1NS(c(cc(cc1)N(C(CC2)=O)S2(=O)=O)c1OC)(=O)=O

InChI

InChI=1S/C17H17ClN2O7S2/c1-26-14-5-3-11(18)9-13(14)19-29(24,25)16-10-12(4-6-15(16)27-2)20-17(21)7-8-28(20,22)23/h3-6,9-10,19H,7-8H2,1-2H3

InChI Key

WPOSCXHPECGNCF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD10480661

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

460.92

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.574

Distribution Coefficient, logD

-0.518

Water Solubility, LogSw

-2.89

Polar Surface Area

100.868

Acid Dissociation Constant (pKa)

5.31

Base Dissociation Constant (pKb)

-10.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.50

D470-0271 in Drug Discovery

Included in Screening Libraries

Nucleic Acid Ligands (8311 compounds)

Targeted Diversity Library (40567 compounds)

Neuropeptide S Library (2850 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Digestive system
  • Nervous system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D470-0271 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D470-0271?
Check Price and Availability of D470-0271, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D470-0271 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D470-0271
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D470-0271
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D470-0271 available by request